[Effects of HMGB1 on Proliferation and Secretion of Human Bone Marrow Mesenchymal Stem Cells].

Shuo Yang,Hong-Yun Liu,Duo-Lan Naren,Guo-Yang Zhang,Xiao-Yan Liu,Peng-Feng Yang,Jie-Yu Wang,Li-Ping Ma

DOI: https://doi.org/10.19746/j.cnki.issn.1009-2137.2021.05.041

2021-01-01

Abstract:Recombinant human HMGB1 can promote the proliferation and secretion of MSC in healthy people.

What problem does this paper attempt to address?

High mobility group box 1 protein inhibits the proliferation of human mesenchymal stem cells and promotes their migration and differentiation along osteoblastic pathway.

Erhong Meng,Zikuan Guo,Hengxiang Wang,Jide Jin,Jinsong Wang,Hua Wang,Cutse Wu,Lisheng Wang

DOI: https://doi.org/10.1089/scd.2008.0276

2008-01-01

Stem Cells and Development

Abstract:Extracellular high mobility group box 1 (HMGB1) is a novel cytokine that takes part in the processes of inflammation, tissue damage and regeneration. Mesenchymal stem cells (MSCs) are adult stem cells characterized by their inherently suppressive activities on inflammative and allo-immune reactions. In the present study, we have addressed whether HMGB1 could affect the biological properties of human bone marrow MSCs. Transwell experiments showed that HMGB1 induced MSC migration and this effect could not be hampered by a blocking antibody against the receptor for advanced glycation end products (RAGE). MSCs exposed to HMGB1 were negative for CD31, CD45, CD80, and HLA-DR, and displayed equal levels of CD73, CD166, and HLA-ABC compared with their counterparts, but HMGB1 profoundly suppressed MSC proliferation in a dose-dependent manner as evaluated by carboxyfluorescein diacetate succinmidyl ester dye dilution assay. Furthermore, HMGB1 triggered the differentiation of MSCs into osteoblasts as identified by histochemical staining, traditional RT-PCR and real-time RT-PCR analysis on mRNA expression of lineage-specific molecular markers. The differentiation-inductive activity could neither be inhibited by RAGE neutralizing antibody. Moreover, HMGB1-treated MSCs displayed unchanged suppressive activity on in vitro lymphocyte cell proliferation elicited by ConA. Collectively, the data suggest that MSCs are a target of HMGB1.
HMGB1 induces migration of human bone marrow-derived mesenchymal stem cells

MENG Er-Hong,GUO Zi-Kuan,LU Zhuo-Zhuang,BIAN Li,WANG Li-Sheng

2006-01-01

Abstract:Objective:To observe the effect of recombinant human high mobility group box1(HMGB1) protein on themigration of human bone marrow derived-mesenchymal stem cells(MSC)in vitro.Methods:Total RNA was extractedfrom the mononuclear cells of normal adult,and the full-length HMGB1 cDNA obtained by RT-PCR was cloned onto ex-pression vector pET-24a-d(+).Expression of the(His)6-HMGB1 fusion protein was induced by addition of IPTG.Thebacterial lysate was subjected to affinity purification using HiTrap Chelating column.The effect of recombinant HMGB1 onthe migration of MSC from human bone marrowin vitrowas observed,and the receptors for HMGB1 on MSC were detectedby RT-PCR.Results:The recombinant HMGB1 was expressed and purified.Human bone marrow-derived MSC express thetwo of known-receptors for HMGB1,i.e.receptor for advanced glycation end product(RAGE) and Toll-like receptor 4(TLR-4).Furthermore,HMGB1 induces the migration of human bone marrowderived-MSCin vitro.Conclusion:The re-combinant HMGB1 protein could induce the migration of MSC,which might be mediated by RAGE and /or TLR-4.
Effects of HMGB1 on human cord blood CD34~+ hematopoietic stem cells proliferation and differentiation in vitro

Xing-bing WANG,Xin CHEN,Kai-di SONG,Jian WANG,Wen YAO,Hui-lan LIU,Zi-min SUN

DOI: https://doi.org/10.3760/cma.j.issn.0253-2727.2010.02.004

2010-01-01

Abstract:Objective To study both the release of HMGB1 from irradiation-treated mesenchymal stem cells (MSCs) and the effects of HMGB1 on human cord blood CD34~+ hematopoietic progenitor cell proliferation and differentiation.Methods MSCs were obtained from human bone marrow.HMGBI released by the MSCs after treatment with 12 Gy γ-ray irradiation was determined by enzyme linked immunosorbent assay (ELISA).CD34~+ cells were positively selected with a MACS CD34 isolation kit.The freshly isolated CD34~+ cells were cultured in the presence of HMGB1 for 6 days.Phenotype of cultured cells surface molecules (CD13,CD14,CD11c,CD41 and CD71) were analyzed by flow cytometry.The proliferation and differentiation capacities of cord blood HSCs were assayed by colony forming cell assay.The receptors of HMGB1 (RAGE,TLR2 and TLR4) on cord blood CD34~+ cells were detected by flow cytometry.Results HMGB1 level in the supernatant [(4.3±0.9) ng/ml]of the irradiated MSC was significantly higher than that in control [(0.4±0.2) ng/ml](P＜0.01).Human cord blood CD34~+ cells expressed the HMGB1 receptors RAGE,TLR2 and TLR4.The HMGB1-treated CD34 + cells contained higher proportions of CD13 + [(32.6±5.9)% vs (18.4±3.8)%],CD14+ [(25.4±4.4)% vs (12.6±2.7)%],CD11c+ [(20.3±3.9)% vs (9.8±2.1) %],CD71 + [(47.1±7.4) % vs (26.6±4.6) %]cells compared with control group did.But HMGBi did not induce the generation of CD41 + cells [(1.3±0.5)% vs (1.1±0.4)%].Furthermore,HMGBI profoundly induced the growth of BFU-E,CFU-GM and total CFU in a dose-dependent manner,and this effect was partially inhibited by TLR2 and TLR4 antibodies.Conclusion Human MSC treated with γray irradiation can release HMGB1,which can induce the proliferation and differentiation of human cord CD34 + cells.
Hmgb1 Promotes the Secretion of Multiple Cytokines and Potentiates the Osteogenic Differentiation of Mesenchymal Stem Cells Through the Ras/Mapk Signaling Pathway

Lin Feng,Deting Xue,Erman Chen,Wei Zhang,Xiang Gao,Jiawei Yu,Yadong Feng,Zhijun Pan

DOI: https://doi.org/10.3892/etm.2016.3857

IF: 2.7

2016-01-01

Experimental and Therapeutic Medicine

Abstract:High mobility group box 1 (HMGB1) protein has been previously been detected in the inflammatory microenvironment of bone fractures. It is well known that HMGB1 acts as a chemoattractant to mesenchymal stem cells (MSCs). In the present study, the effects of HMGB1 on cytokine secretion from MSCs were determined, and the molecular mechanisms underlying these effects of HMGB1 on osteogenic differentiation were elucidated. To detect cytokine secretion, antibody array assays were performed, which demonstrated that HGMB1 induced the differential secretion of cytokines that are predominantly associated with cell development, regulation of growth and cell migration, stress responses, and immune system functions. Moreover, the secretion of epidermal growth factor receptor (EGFR) was significantly upregulated by HMGB1. The EGFR-activated Ras/MAPK pathway regulates the osteogenic differentiation of MSCs. These results suggested that HMGB1 enhances the secretion of various cytokines by MSCs and promotes osteogenic differentiation via the Ras/MAPK signaling pathway. The present study may provide a theoretical basis for the development of novel techniques for the treatment of bone fractures in the future.
Extracellular HMGB1 Enhances Proliferation, Differentiation and Migration of Human CD34+ Hematopoietic Stem Cells in Vitro

Xingbing Wang,Xin Chen,Weihua Ren,Xiucai Xu,Kaidi Song,Huilan Liu,Zimin Sun,Shiang Huang

DOI: https://doi.org/10.1182/blood.v112.11.4744.4744

IF: 20.3

2008-01-01

Blood

Abstract:High-mobility group box 1 protein (HMGB1) is a chromatin protein and acts as a cytokine involved in inflammation, cell proliferation, differentiation, migration and stem cell recruitment. So far, little is known about its effect on hematopoietic stem cells (HSCs). In this study, we investigated whether receptors for HMGB1 are expressed on human CD34+ HSCs, and whether HMGB1 could affect HSCs proliferation, differentiation and migration in vitro. As examined by FACS analysis and RT-PCR, cord blood CD34+ HSCs express the HMGB1 receptors RAGE (receptor for advanced glycation end products), TLR2 (Toll-like receptor 2) and TLR4. To study the effects of HMGB1 on CD34+ HSCs proliferation and differentiation, freshly isolated cord blood CD34+ HSCs were cultured for 7 days in medium alone or in the presence of HMGB1. Flow cytometric analysis showed that HMGB1 (50ng/ml) can induce the differentiation of CD34+ HSCs along the granulo-monocytic (CD14+, CD13+) lineage and erythropoiesis (CD71+). In contrast, HMGB1 did not induce the expression of CD41, a marker for megakaryocyte lineage. The numbers of cells cultured in the presence of HMGB1 were always increased in comparison with controls. Furthermore, higher numbers of granulomonocytic progenitors (CFU-GM), erythroid progenitors (BFU-E), and CFU-MIX were confirmed by CFC assays in a HMGB1 dose dependent manner after 14-day culture. The results suggest that HMGB1 enhances CD34+ HSCs proliferation and differentiation. We next assessed the effects of HMGB1 on HSCs migration by chemotaxis assay using Boyden chambers. HMGB1 dose-dependently increased the chemotactic migration of CD34+ HSCs. A neutralizing anti-RAGE antibody significantly blocked the HMGB1-induced migration of HSCs, whereas neutralizing TLR2 and TLR4 antibodies did not significantly influence HMGB1-stimulated HSCs migration, suggesting that the migratory effect of HMGB1 on human HSCs is predominantly mediated by RAGE. In summary, our results provide the first report of HMGB1 receptors expression profile of human cord blood CD34+ HSCs and demonstrate that HMGB1 can increase the proliferation and migration of HSCs and directly induce of HSCs along myeloid differentiation and erythropoiesis in vitro. Further studies will be needed to clarify the mechanism of HMGB1 activation and the physiological function of HMGB1 in HSCs in vivo.
Signaling Pathways Involved In The Effects Of Hmgb1 On Mesenchymal Stem Cell Migration And Osteoblastic Differentiation

Feng Lin,Wei Zhang,Deting Xue,Ting Zhu,Jin Li,Erman Chen,Xueyu Yao,Zhijun Pan

DOI: https://doi.org/10.3892/ijmm.2016.2479

IF: 5.314

2016-01-01

International Journal of Molecular Medicine

Abstract:High mobility group box 1 (HMGB1) epxression has been found in the inflammatory microenvironment of fractures. It is well known that HMGB1 acts as a chemoattractant for mesenchymal stem cells (MSCs); however, the effects of HMGB1 on MSC migration and osteoblastic differentiation, and the signaling pathways involved in these effects, have not yet been elucidated. In this study, we aimed to investigate these effects, as well as the signaling mechanisms involved, using in vitro models. We found that HMGB1, in varying concentrations, promoted the osteoblastic differentiation of MSCs, the synthesis of receptor for advanced glycation end products (RAGE) and Toll-like receptor (TLR)2/4, and the activation of the p38 mitogen-activated protein kinase (MAPK) and nuclear factor-kappa B (NF-kappa B) signaling pathways. Subsequently, we cultured the MSCs in the appropriate concentration of HMGB1, and determined the signaling pathways involved in the effects of HMGB1 on MSC migration and differentiation, using receptor neutralizing antibodies and signaling pathway inhibitors. From the results of this study, we concluded that HMGB1 promotes MSC migration through the activation of the p38 MAPK signaling pathway, and also promotes MSC differentiation by binding to TLR2/4 and activating the p38 MAPK signaling pathway. These findings elucidate the mechanisms underlying the effects of HMGB1 in the fracture microenvironment, which may provide a theoretical basis for the development of improved clinical treatments for fractures.
HMGB1 promotes cellular chemokine synthesis and potentiates mesenchymal stromal cell migration via Rap1 activation.

Feng Lin,Deting Xue,Tao Xie,Zhijun Pan

DOI: https://doi.org/10.3892/mmr.2016.5398

IF: 3.423

2016-01-01

Molecular Medicine Reports

Abstract:The migration of mesenchymal stem cells (MSCs) and osteogenic differentiation occupy an important role in fracture healing. High mobility group box 1 (HMGB1), a widely distributed inflammatory factor in fractures, has been confirmed to act as a chemoattractant to MSCs. To investigate the effect of HMGB1 on MSC migration and the underlying mechanism, the synthesis of MSC chemokines, and the consequent activation of signaling pathways following HMGB1 stimulation, were evaluated. A Quantibody (R) array was performed to determine which chemokines were secreted from MSCs with or without treatment with HMGB1. The results indicated differential chemokine synthesis by MSCs following treatment with HMGB1, including that of CCL4 and CCL13. In addition, the Ras-associated protein-1 (Rap1) signaling pathway was markedly activated in the HMGB1-treated groups, suggesting that HMGB1 may enhance the migrational ability of MSCs via Rap1 activation. Furthermore, HMGB1 was able to promote the secretion of various chemokines derived from MSCs, which would, in turn, increase the mobility of MSCs. Taken together, these results provide a mechanistic basis for developing novel approaches to promote fracture healing.
Effects of HMGB1/TLR4 on secretion IL-10 and VEGF in human jaw bone-marrow mesenchymal stem cells

Jingjing Kong,Wei Cheng,Lianzhen Chang,Jingyi Yu,Ronglin Wang,Jianli Xie

DOI: https://doi.org/10.1590/1678-7757-2023-0304

2024-01-01

Journal of Applied Oral Science

Abstract:OBJECTIVE: We aimed to investigate the regulatory effects of HMGB1/TLR4 signaling pathway on the expression of IL-10 and VEGF in human bone marrow mesenchymal stem cells.METHODOLOGY: Human JBMSCs were isolated and cultured. Then, HMGB1 was added into the JBMSCs culture medium, and the protein and mRNA expression levels of IL-10 and VEGF were assessed. Moreover, cells were pretreated with a specific TLR4 inhibitor (TAK-242), and the expression changes of IL-10 and VEGF were compared.RESULTS: Compared with the control group, exposure to HMGB1 in human JBMSCs up-regulated TLR4, IL-10, and VEGF secretion at both protein and mRNA levels (P<0. 05). In addition, the increased expression of IL-10 and VEGF could be restrained in TAK-242 group compared with the HMGB1 group (P<0.05).CONCLUSIONS: The results indicated that HMGB1 activate TLR4 signaling pathway in Human JBMSCs, which plays a regulatory role in cytokines expression.

dentistry, oral surgery & medicine
Influence of Human Bone Marrow Mesenchymal Stem Cells on Proliferation of Chronic Myeloid Leukemia Cells.

Hai-Mei Zhang,Lian-Sheng Zhang

DOI: https://doi.org/10.3321/j.issn:1000-467x.2009.01.007

2009-01-01

Abstract:BACKGROUND AND OBJECTIVE:Bone marrow mesenchymal stem cells (MSCs) are of particular interest due their potential clinical use in tissue engineering. MSCs could secret soluble factor(s) upon stimulation. This study was to evaluate the influence of human bone marrow MSCs on proliferation of chronic myeloid leukemia cells, and assess the secretion of cytokines in the supernatant induced by MSCs.METHODS:Bone marrow MSCs extracted from healthy donors were cultured in DMEM-LG. The surface markers on the third passage MSCs were detected by flow cytometry. MSCs were co-cultured with chronic myeloid leukemia mononuclear cells (CML-MNCs) at various ratios. Cell proliferation was measured by flow cytometry. The interferon (IFN)-alpha level in the supernatant was analyzed by ELISA assay.RESULTS:The primary and passaged MSCs mostly appeared fibroblast-like and showed strong capacity of growth and reproduction. The membrane marker CD44 was positive and CD45 was negative on the surface of MSCs. Co-culture of MSCs with CML-MNC significantly inhibited the proliferation of CML-MNC. The IFN-alpha level in the supernatant of cell culture was significantly higher in the co-culture groups than in the CML-MNC control group (p < 0.001). Secretion of IFN-alpha was elevated with the increase of the MSC concentration and co-culture duration.CONCLUSION:Co-culture of MSCs with CML could secrete a substantial amount of IFN-alpha, thus to inhibit the proliferation of CML cells.
Effects of HMGB1 on proliferative and metastatic abilities of hepatoma cell line HepG2

LIU Ya-ping,DONG Lei,Haitao Shi,LIU Xin,Xiaolan Lu,JIANG Jiong

2013-01-01

Abstract:Objective To investigate effects of high mobility group box-1(HMGB1) on the proliferative and metastatic abilities of hepatoma cell line HepG2 in vitro and analyze the possible mechanisms.Methods MTT was used to determine the proliferative and adhesive abilities of HepG2.The invasive and migratory abilities were detected by Transwell assay.The protein and mRNA expressions of matrix metalloproteinases-2(MMP-2),matrix metalloproteinases-9(MMP-9) and vascular endothelial growth factor(VEGF) were evaluated by Western blot and reverse transcription(RT-PCR),respectively.Results The proliferative ability of HepG2 in response to rHMGB1 of different concentrations(10,100 and 1 000 ng/mL) was significantly higher than that in the control group at 24,48 and 72 h(P<0.01),and it increased with the increase of treatment concentration and time.HepG2 was treated by rHMGB1(100 ng/mL) for 48 h to detect the adhesive,invasive and migratory abilities.Compared to the control group,the adhesive ability of HepG2 to Matrigel was significantly elevated(P<0.01) and the number of invasive and migratory cells was remarkably increased(P<0.01).In addition,the protein and mRNA expressions of MMP-9 and VEGF were significantly up-regulated(P<0.01),but there was no difference in the protein and mRNA expressions of MMP-2(P>0.05).Conclusion The proliferative,adhesive,invasive and migratory abilities of hepatoma cells can be promoted by HMGB1,which may be related to up-regulating the protein and mRNA expressions of MMP-9 and VEGF.
Effects of High-Mobility Group Box 1 on the Proliferation and Odontoblastic Differentiation of Human Dental Pulp Cells

S. C. Qi,C. Cui,Y. H. Yan,G. H. Sun,S. R. Zhu

DOI: https://doi.org/10.1111/iej.12112

2013-01-01

International Endodontic Journal

Abstract:Aim To investigate the expression of high-mobility group box 1 (HMGB1) in human dental pulp tissues and the effects of HMGB1 on proliferation and odontoblastic differentiation of human dental pulp cells (hDPCs).Methodology Immunohistochemical assay, immunofluorescence staining and flow cytometric analysis were used to detect the expression of HMGB1 in the human dental pulp and hDPCs, respectively. The proliferation of hDPCs was examined by CCK-8 after culturing human primary hDPCs in the presence of HMGB1 with different doses. Odontoblastic differentiation of hDPCs was determined using alkaline phosphatase (ALPase) activity assay and mineralized nodule formation. Important mineralization-related genes such as ALP, dental sialophosphoprotein (DSPP) and dental matrix protein-1 (DMP-1) were determined by real-time polymerase chain reaction. Western blot analysis was performed to determine the difference in expressions of DMP-1 and DSP with or without the presence of exogenous HMGB1. Simultaneously, messenger RNA and protein levels of HMGB1 and RAGE were also detected. The protein level of HMGB1 in the supernatants was quantified using ELISA analysis.Results HMGB1 was found in human dental pulp tissue and in the nuclei of hDPCs. During hDPC odontoblastic differentiation, HMGB1 translocated from the nuclei to the cytoplasm and then secreted out from hDPCs. Exogenous HMGB1 promoted hDPC proliferation and mineralized nodule formation. It up-regulated the activity of ALPase and the mRNA and protein levels of dentine matrix protein-1 (DMP-1), alkaline phosphatase (ALP), dentine sialophosphoprotein (DSPP) and receptor for advance glycation end (RAGE) of hDPCs.Conclusion HMGB1 promoted the proliferation and odontoblastic differentiation of hDPCs.
The Effects of HMGB1 on the Migration and Proliferation of Human Dental Pulp Cells

Shu Zhu

2013-01-01

Abstract:Objective:To investigate the expression of high-mobility group box 1(HMGB1) in human dental pulp cells and the effects of HMGB1 on proliferation and migration of human dental pulp cells(hDPCs).Method:An immunoflurescence staining was used to detect the expression of HMGB1 in the primary hDPCs.The proliferation of hDPCs was examined using CCK8 after culturing primary hDPCs in the presence of HMGB1 with different doses(0.1 ng/mL,1 ng/mL,10 ng/mL,50 ng/mL,100 ng/mL,500 ng/mL,1000 ng/mL) for 5 days.The migration of hDPCs was evaluated using Scratch Test after culturing hDPCs in the concentration of 1 ng/mL HMGB1 for 24 h.Result:HMGB1 was found present in nucleus of primary hDPCs.Exogenous HMGB1 promoted the hDPCs proliferation at the concentration of 0.1 ng/mL,1 ng/mL,10 ng/mL,50 ng/mL,100 ng/mL and significantly promoted the migration at the concentration of 1 ng/mL.Conclusion:HMGB1 was present in nucleus of hDPCs and exogenous low concentration HMGB1 promoted the proliferation and migration of hDPCs.
[Effect of Bone Marrow Mesenchymal Stem Cells on Tumor Neovascularization].

Xu He,Xin-rui Wang,Xu-fang Yang,Li-hong Zhang,Yun Niu,Yu-lin Li

DOI: https://doi.org/10.3760/cma.j.issn.0529-5807.2010.07.006

2010-01-01

Abstract:OBJECTIVE:The effect of human bone marrow mesenchymal stem cells (hMSCs) on tumor neovascularization were studied.METHODS:hMSCs were isolated from human bone marrow by density gradient fractionation and adherence to plastic flasks. hMSCs-EGFP were obtained by pLEGFP-N1 retroviral vector. Flow cytometry was used to detect the cell surface antigen and the differentiation potential of hMSCs-EGFP was investigated under conditioned media. The effect of hMSCs on tumor neovascularization were observed by establishing solid tumor models in BALB/C nude mice. In addition, effect of the conditioned medium used for tumor cells and endothelial cells (EC) cultivation was collected, to detect its effect on the growth and migration rates of hMSC. hMSCs were induced to differentiate into EC in vitro and the migratory effect on HUVEC was also evaluated.RESULTS:hMSCs-EGFP, like hMSC, exhibited a fibroblast-like morphological feature, and both had the similar cell surface antigens. They could be induced into osteocytes or adipocytes under the conditioned media. The results not only suggested that hMSCs contributed to tumor neovascularization, but also indicated that most of vessels were host-derived angiogenesis mediated by hMSCs. The mean vascular density (MVD) in suspension group (13.67 ± 1.53) was strikely higher than that in MCF-7 group (5.33 ± 1.42), which showed statistical significance (P < 0.05). Only very few vessels were attributed to hMSCs transdifferentiation into ECs. Tumor cells and ECs can promote hMSCs proliferation and migration through paracrine action. Furthermore, hMSCs were positive for CD31 after 2 weeks induction and HUVEC migration can be facilitated by hMSCs.CONCLUSION:MSCs have the effect of promoting tumor neovascularization.
Effects of PTH on hMSCs proliferation, differentiation, stemness and paracrine

Wen-jing TANG,Yan-ping DU,Hong Wei,Hui-lin LI,Qun CHENG

DOI: https://doi.org/10.3969/j.issn.1674-2591.2014.01.008

2014-01-01

Abstract:Objective To investigate the effects of parathyroid hormone (PTH) on proliferation, differentia-tion, stemness and paracrine of human mesenchymal stem cells ( hMSCs ) .Methods hMSCs were bought from Lonza . hMSCs were divided into two groups:CON, hMSCs were cultured by normal medium;PTH, cultured by normal medium with PTH.Cell proliferation was detected by cell counting and BrdU incorporation .Cell differentiation was detected using ALP, Oil Red O and Alcian Blue staining .mRNA expression of OCT-4, Nanog, SOX-2 and CCND1, C-MYC of hMSCs were measured by Realtime PCR .Protein concentrations of SDF-1, IGF-1, VEGF, BMP2 and Angiopoietin1 in hMSCs culture medium were tested by ELISA .Results PTH 10 -8 -10 -9 mol/L increased proliferation of hMSCs at day 6 ( P<0.05 ) , and PTH 10 -8 mol/L promoted osteogenesis and chondrogenesis , inhibited adipogenesis of hMSCs .PTH 10 -8 mol/L induce the gene expression of CCND 1 ( P<0.01 ) and C-MYC ( P<0.01 ) , and suppressed the gene expression of OCT-4 (P<0.01), Nanog (P<0.05) and SOX-2 (P<0.05) in vitro.PTH 10 -8 mol/Lalso increased the protein concentration of SDF-1 (P<0.05), IGF-1 (P<0.05), BMP2 (P<0.05) and Angiopoietin1 (P<0.05) in cell cul-ture medium which shows great important in regulation and communication of hMSCs with other tissue around microenvi -ronment .Conclusion PTH greatly regulated hMSCs differentiation , and moderately promoted hMSCs proliferation , how-ever, PTH cann't maintain hMSCs stemness .PTH regulated paracrine action of hMSCs , which promoted anabolism , mi-gration and angiogenesis .
[Human Bone Marrow Mesenchymal Stem Cells Express Multiple Hematopoietic Growth Factors].

Guang-Rong Zhu,Xiao-Yu Zhou,Hua Lu,Jian-Wei Zhou,Ai-Ping Li,Wei Xu,Jian-Yong Li,Cheng-Ya Wang

DOI: https://doi.org/10.3969/j.issn.1009-2137.2003.02.002

2003-01-01

Abstract:To study the biological role of human cultured bone marrow mesenchymal stem cell (BM-MSC) in hematopoiesis by investigation of its expression of multiple hematopoietic growth factors, RT-PCR was used to analyze the expression of SCF, Flt3-ligand, TPO, LIF, G-CSF, GM-CSF, IL-3, IL-6 and IL-11 at mRNA level for human BM-MSC from healthy donors and patients with leukemia and lymphoma. BM-MSC were incubated with or without hydrocortison (HC). The results clearly showed that the cultured BM-MSC expressed mRNA of SCF, Flt3-ligand, TPO, LIF, IL-6 and IL-11 at passages 3 up to 15, but did not express G-CSF, GM-CSF and IL-3. The same expression pattern of above cytokines was seen also for the patient's BM-MSC. HC was able to induce BM-MSC to express G-CSF but not to express GM-CSF. BM-MSC seemed not to change morphologically after incubation with HC for up to 21 days. In conclusion, both normal and patient BM-MSC should be potential to promote hematopoiesis according to their expression of multiple hematopoietic cytokines, and HC is able to induce hematopoietic growth factor expression.
The protective effects of HMGA2 in the senescence process of bone marrow derived mesenchymal stromal cells.

Ziying Yang,Xuan Liu,Longgang Wang,Tao Wang,Yueqiu Chen,Xiaomei Teng,Jingjing Li,Lianbo Shao,Jie Hui,Wenxue Ye,Zhenya Shen

DOI: https://doi.org/10.1002/term.3023

2020-01-01

Journal of Tissue Engineering and Regenerative Medicine

Abstract:Bone marrow-derived mesenchymal stromal cells (MSCs) have been wildly applied to cell-based strategies for tissue engineering and regenerative medicine; however, they have to undergo the senescence process and thus appeared to be less therapeutic effective. HMGA2, a protein belonged to high mobility group A (HMGA) family, exhibits an inverse expression level related to embryonic development and acts as a developmental regulator in stem cell self-renewal progression. Therefore, we performed senescence-associated beta-galactosidase (SA-beta-gal) staining, transwell assay, to examine the changes of MSCs in different stages and then over-expressed HMGA2 in MSCs by lentivirus transfection. We found the percentage of SA-beta-gal staining positive cells in MSCs from 24-month-old Sprague-Dawley (SD) rats (O-MSCs) was significantly higher compared with MSCs from 2-week-old SD rats (Y-MSCs), and the expression levels of P21 and P53, two senescence-related molecules, were also significantly up-regulated in O-MSCs than in Y-MSCs. In contrast, the HMGA2 expression level in O-MSCs was dramatically down-regulated in contrast to Y-MSCs. In additional, the migration ability in O-MSCs was significantly attenuated than in Y-MSCs. After successfully over-expressed HMGA2 in O-MSCs, the percentage of SA-beta-gal staining positive cells and the expression levels of P21 and P53 were reduced, and the migration ability was improved compared with O-MSCs without treatment. Further, mRNA sequencing analysis revealed that overexpression of HMGA2 changed the expression of genes related to cell proliferation and senescence, such as Lyz2, Pf4, Rgs2, and Mstn. Knockdown of Rgs2 in HMGA2 overexpression O-MSCs could antagonize the protective effect of HMGA2 in the senescence process of O-MSCs.
[Effects of Human Umbilical Cord Mesenchymal Stem Cells on the Proliferation of Hematopoietic Malignancies].

Yilin Pang,Yongyong Tang,Qian Li,Jing Xie,Xuefeng Zang,Tingting Liu,Bin Zhang,Hu Chen

2013-01-01

Abstract:OBJECTIVE:To study the effects of human umbilical cord mesenchymal stem cells (UC-MSCs) on proliferation of eight tumor cell lines from leukemia, lymphoma and multiple myeloma in vitro.METHODS:Tumor cells were labeled with carboxyfluorescein diacetate succinimidyl ester (CFDA-SE). UC-MSCs were co-cultured with tumor cells at different ratios as experimental groups, meanwhile, tumor cells were cultured without UC-MSCs as control groups. After three days, mean fluorescence intensity and cell division generations of the tumor cells were measured by flow cytometry.RESULTS:UC-MSCs inhibited the proliferation of HL60, THP1, K562 and RPMI8226 cell lines, but promoted the proliferation of Raji and NCIH929 cell lines. UC-MSCs promoted the proliferation of Jurkat cells only at 1:1 ratio; as for U937 cells, UC-MSCs inhibited the proliferation at 2:1 ratio (UC-MSCs: U937), promoted proliferation at 1:4 and 1:16, whereas had no obvious effect at 1:1.CONCLUSION:UC-MSCs have different effects on the proliferation of different hematopoietic tumor cell lines. They have no promoting effects on four leukemic cell lines, but have bidirectional (promotion/inhibition) effects on lymphoma and multiple myeloma cell lines. The U937 cell line may serve as a good model for the mechanism study of this contradictory phenomenon.
High Mobility Group Box 1 (HMGB1): a Pivotal Regulator of Hematopoietic Malignancies

Shunling Yuan,Zhaoping Liu,Zhenru Xu,Jing Liu,Ji Zhang

DOI: https://doi.org/10.1186/s13045-020-00920-3

IF: 28.5

2020-01-01

Journal of Hematology & Oncology

Abstract:High mobility group box 1 (HMGB1) is a nonhistone chromatin-associated protein that has been widely reported to play a pivotal role in the pathogenesis of hematopoietic malignancies. As a representative damage-associated molecular pattern (DAMP), HMGB1 normally exists inside cells but can be secreted into the extracellular environment through passive or active release. Extracellular HMGB1 binds with several different receptors and interactors to mediate the proliferation, differentiation, mobilization, and senescence of hematopoietic stem cells (HSCs). HMGB1 is also involved in the formation of the inflammatory bone marrow (BM) microenvironment by activating proinflammatory signaling pathways. Moreover, HMGB1-dependent autophagy induces chemotherapy resistance in leukemia and multiple myeloma. In this review, we systematically summarize the emerging roles of HMGB1 in carcinogenesis, progression, prognosis, and potential clinical applications in different hematopoietic malignancies. In summary, targeting the regulation of HMGB1 activity in HSCs and the BM microenvironment is highly beneficial in the diagnosis and treatment of various hematopoietic malignancies.
Regulation of high mobility group box 1 and hypoxia in the migration of mesenchymal stem cells.

Hong-Lei Xie,Yi Zhang,Yi-Zhou Huang,Shun Li,Cheng-Guang Wu,Xue-Feng Jiao,Mei-Yun Tan,Yong-Can Huang,Li Deng

DOI: https://doi.org/10.1002/cbin.10279

IF: 4.473

2014-01-01

Cell Biology International

Abstract:Mesenchymal stem cells (MSCs) have been increasingly offered for tissue regeneration with the premise that they can survive and thrive amidst the microenvironment of injured or degenerate tissues. The role of high mobility group box 1 (HMGB1) and hypoxia in the proliferation and migration of rat bone marrow MSCs (rBM-MSCs) has been investigated. First, the effect of HMGB1 on the proliferation of rBM-MSCs was determined. Second, to evaluate the regulation of hypoxia and HMGB1 in the migration of rBM-MSCs, cells in the wound healing model were exposed to four conditions: normoxia (20% O-2) and complete medium, normoxia and HMGB1, hypoxia (1% O-2) and complete medium, hypoxia and HMGB1. RT-PCR and Western blotting were used to measure the expression of migration-related genes and proteins. HMGB1 inhibited the proliferation of rBM-MSCs; HMGB1 alone or together with hypoxia and promoted the migration of MSCs and upregulated the expression of HIF-1 alpha and SDF-1. These results demonstrated that HMGB1 arrested the proliferation of rBM-MSCs, but enhanced the migration of rBM-MSCs which could be further improved by hypoxia. This study strengthens current understanding of the interaction between MSCs and the microenvironment of damaged tissues.
Hepatocyte growth factor gene modification enhancing immunosuppressive activity of human bone marrow-derived mesenchymal stem cells

BIAN Li,GUO Zi-Kuan,AI Hui-Sheng,WANG Hua,MENG Er-Hong,WANG Li-Sheng

DOI: https://doi.org/10.3969/j.issn.1674-9960.2006.04.006

2006-01-01

Abstract:Objective: To explore the effect of over-expression of hepatocyte growth factor(HGF)gene in mesenchymal stem cell(MSC)on cell biology in order to provide a basis for novel clinical use of MSC.Methods: The phenotype was assessed by flow cytometric analysis and cell proliferation was determined by MTT test.In vitro differentiation of MSC into osteoblasts and adipoblasts was evaluated by lineage-specific histochemical staining.Furthermore,the inhibitory effect of MSC-HGF on lymphocyte proliferation in mixed lymphocyte reaction was determined by ~(3)H-TdR incorporation assay.Results: MSC over-expressing HGF exhibited unchanged phenotype,proliferation and differentiation properties as compared with the control.However,in the mixed lymphocyte reaction,MSC-HGF could inhibit lymphocyte proliferation induced by heterogenic antigen in a dose-dependent manner.When the ratio of MSC to lymphocyte cells was 1∶80,the proliferation of lymphocytes decreased by 19.8% in the MSC group and by 68.3% in the MSC-HGF group,which was 3.45 times that of the MSC group.Conclusion: Human bone marrow-derived MSCs modified by HGF gene maintain their inherent proliferative and differentiative ability,and show more potent immunosuppressive effect on in vitro cellular immune reaction,suggesting the novel clinical potentials of MSC in hepatopoietic stem cell transplantation or organ transplantation.

[Effects of HMGB1 on Proliferation and Secretion of Human Bone Marrow Mesenchymal Stem Cells].

High mobility group box 1 protein inhibits the proliferation of human mesenchymal stem cells and promotes their migration and differentiation along osteoblastic pathway.

HMGB1 induces migration of human bone marrow-derived mesenchymal stem cells

Effects of HMGB1 on human cord blood CD34~+ hematopoietic stem cells proliferation and differentiation in vitro

Hmgb1 Promotes the Secretion of Multiple Cytokines and Potentiates the Osteogenic Differentiation of Mesenchymal Stem Cells Through the Ras/Mapk Signaling Pathway

Extracellular HMGB1 Enhances Proliferation, Differentiation and Migration of Human CD34+ Hematopoietic Stem Cells in Vitro

Signaling Pathways Involved In The Effects Of Hmgb1 On Mesenchymal Stem Cell Migration And Osteoblastic Differentiation

HMGB1 promotes cellular chemokine synthesis and potentiates mesenchymal stromal cell migration via Rap1 activation.

Effects of HMGB1/TLR4 on secretion IL-10 and VEGF in human jaw bone-marrow mesenchymal stem cells

Influence of Human Bone Marrow Mesenchymal Stem Cells on Proliferation of Chronic Myeloid Leukemia Cells.

Effects of HMGB1 on proliferative and metastatic abilities of hepatoma cell line HepG2

Effects of High-Mobility Group Box 1 on the Proliferation and Odontoblastic Differentiation of Human Dental Pulp Cells

The Effects of HMGB1 on the Migration and Proliferation of Human Dental Pulp Cells

[Effect of Bone Marrow Mesenchymal Stem Cells on Tumor Neovascularization].

Effects of PTH on hMSCs proliferation, differentiation, stemness and paracrine

[Human Bone Marrow Mesenchymal Stem Cells Express Multiple Hematopoietic Growth Factors].

The protective effects of HMGA2 in the senescence process of bone marrow derived mesenchymal stromal cells.

[Effects of Human Umbilical Cord Mesenchymal Stem Cells on the Proliferation of Hematopoietic Malignancies].

High Mobility Group Box 1 (HMGB1): a Pivotal Regulator of Hematopoietic Malignancies

Regulation of high mobility group box 1 and hypoxia in the migration of mesenchymal stem cells.

Hepatocyte growth factor gene modification enhancing immunosuppressive activity of human bone marrow-derived mesenchymal stem cells